blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3230741

EP3230741 - ANTI-CARBAPENEMASE ANTIBODIES AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.10.2020
Database last updated on 16.09.2024
FormerGrant of patent is intended
Status updated on  14.11.2019
FormerExamination is in progress
Status updated on  30.09.2019
FormerGrant of patent is intended
Status updated on  30.05.2019
FormerExamination is in progress
Status updated on  05.10.2018
FormerRequest for examination was made
Status updated on  15.09.2017
FormerThe international publication has been made
Status updated on  12.07.2017
Most recent event   Tooltip09.10.2020Application deemed to be withdrawnpublished on 11.11.2020  [2020/46]
Applicant(s)For all designated states
Alere Technologies GmbH
Löbstedter Straße 103 - 105
07749 Jena / DE
[2019/26]
Former [2017/42]For all designated states
Alere Technologies GmbH
Loebstedterstrasse 103 - 105
07749 Jena / DE
Inventor(s)01 / EHRICHT, Ralf
Beutnitzer Strasse 6
07749 Jena / DE
02 / BUECHLER, Joseph
1343 Cassins Street
Carlsbad, California 92011 / US
03 / MÜLLER, Elke
Dornburger Strasse 126
07743 Jena / DE
04 / BRAUN, Sascha
Schützenhofstrasse 32
07743 Jena / DE
05 / MONECKE, Stefan
Erich-Weinert-Strasse 3
07749 Jena / DE
06 / REISSIG, Annett
Eisenberger Strasse 6
07749 Jena / DE
[N/P]
Former [2017/42]01 / EHRICHT, Ralf
Beutnitzer Strasse 6
07749 Jena / DE
02 / BUECHLER, Joseph
1343 Cassins Street
Carlsbad, California 92011 / US
03 / MÜLLER, Elke
Dornburger Strasse 126
07743 Jena / DE
04 / BRAUN, Sascha
Schützenhofstrasse 32
07743 Jena / DE
05 / MONECKE, Stefan
Erich-Weinert-Strasse 5
07749 Jena / DE
06 / REISSIG, Annett
Eisenberger Strasse 6
07749 Jena / DE
Representative(s)Huenges, Martin
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2017/42]Huenges, Martin
Maiwald Patentanwalts GmbH
Elisenhof
Elisenstrasse 3
80335 München / DE
Application number, filing date15808247.911.12.2015
[2017/42]
WO2015EP79487
Priority number, dateUS201462090561P11.12.2014         Original published format: US 201462090561 P
GB2015000338727.02.2015         Original published format: GB 201503387
[2017/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016092096
Date:16.06.2016
Language:EN
[2016/24]
Type: A1 Application with search report 
No.:EP3230741
Date:18.10.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 16.06.2016 takes the place of the publication of the European patent application.
[2017/42]
Search report(s)International search report - published on:EP16.06.2016
ClassificationIPC:G01N33/573, C07K16/12
[2017/42]
CPC:
G01N33/573 (EP); C07K16/1203 (EP); G01N2333/986 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/42]
TitleGerman:ANTI-CARBAPENEMASE-ANTIKÖRPER UND VERWENDUNGEN DAVON[2017/42]
English:ANTI-CARBAPENEMASE ANTIBODIES AND USES THEREOF[2017/42]
French:ANTICORPS ANTI-CARBAPÉNÉMASES ET LEURS UTILISATIONS[2017/42]
Entry into regional phase11.07.2017National basic fee paid 
11.07.2017Designation fee(s) paid 
11.07.2017Examination fee paid 
Examination procedure11.07.2017Examination requested  [2017/42]
11.07.2017Date on which the examining division has become responsible
30.05.2018Amendment by applicant (claims and/or description)
04.10.2018Despatch of a communication from the examining division (Time limit: M04)
12.02.2019Reply to a communication from the examining division
31.05.2019Communication of intention to grant the patent
26.09.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
15.11.2019Communication of intention to grant the patent
03.06.2020Application deemed to be withdrawn, date of legal effect  [2020/46]
26.06.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/46]
Request for further processing for:30.05.2018Request for further processing filed
30.05.2018Full payment received (date of receipt of payment)
Request granted
12.06.2018Decision despatched
Fees paidRenewal fee
12.12.2017Renewal fee patent year 03
12.12.2018Renewal fee patent year 04
10.12.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2011042454  (INST NAT SANTE RECH MED [FR], et al) [A] 1-28 * the whole document, in particular page 19, line 14 to page 20, line 12; claims 1-3 *;
 [XI]WO2013011072  (INST NAT SANTE RECH MED [FR], et al) [X] 1,8-10,12-14,17,19-25,27,28 * the whole document, in particular page 3, lines 12-17; page 4, lines 6-22; page 9, lines 19-29; page 16, lines 3-6; page 18, line 32 to page 20, line 26; page 21, lines 7-10; page 23, lines 6-22; page 25, lines 22-29; page 26, lines 17-33; claims 8, 9 * [I] 2-7,11,15,16,18,26;
 [X]WO2013112696  (LOS ANGELES BIOMED RES INST [US]) [X] 21,22 * the whole document, in particular paragraphs [0049], [0050]; claims 18, 68, 69 *;
 [XI]WO2014160192  (MESO SCALE TECHNOLOGIES LLC [US]) [X] 1,8-10,12-14,17-28 * the whole document, in particular page 54, lines 4-12; page 70, lines 26-31; page 74, lines 13-24; page 76, lines 23-31; page 78, lines 19-24; page 82, lines 17-25; page 91, lines 4-7; claims 1-8, 46-52, 61, 63-65, 67, 68 * [I] 2-7,11,15,16;
 [A]WO2012143535  (BIO MERIEUX INC [US], et al) [A] 1-28 * the whole document *;
 [A]WO2010130882  (LICENTIA LTD [FI], et al) [A] 1-28 * the whole document *;
 [A]  - TOMOE KITAO ET AL, "Development of an immunochromatographic assay for diagnosing the production of IMP-type metallo-beta-lactamases that mediate carbapenem resistance in", JOURNAL OF MICROBIOLOGICAL METHODS, ELSEVIER, AMSTERDAM, NL, vol. 87, no. 3, doi:10.1016/J.MIMET.2011.09.011, ISSN 0167-7012, (20110923), pages 330 - 337, (20111001), XP028109164 [A] 1-28 * the whole document, in particular abstract *

DOI:   http://dx.doi.org/10.1016/j.mimet.2011.09.011
 [XI]  - Anonymous, "New delhi metallo-beta-lactamase-1 (NDM-1) ELISA kit", internet article, (20121012), pages 1 - 14, URL: http://www.hoelzel-biotech.com/media/import/pdf_manual/Cusabio//CSB-E14924__Manual.pdf, (20160215), XP055250159 [X] 1,9,10,12-14,17,19,21,23,25,27,28 * the whole document, in particular page 1, lines 1-6; page 2, first and last paragraphs * [I] 2-8,11,15,16,18,20,22,24,26
 [A]  - HAMMOUDI D ET AL, "How to detect carbapenemase producers? A literature review of phenotypic and molecular methods", JOURNAL OF MICROBIOLOGICAL METHODS, (20141007), vol. 107, doi:10.1016/J.MIMET.2014.09.009, ISSN 0167-7012, pages 106 - 118, XP029098803 [A] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.mimet.2014.09.009
 [XI]  - ANDREA ENDIMIANI ET AL, "Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (20090909), vol. 64, pages 1102 - 1110, XP055250179 [X] 1,9-12,19,21,23,25,27,28 * the whole document in particular abstract; page 1104, section "immunoblotting"; page 1106, section "expression levels of KPC enzymes ..."; figure 1 * [I] 2-8,13-18,20,22,24,26

DOI:   http://dx.doi.org/10.1093/jac/dkp327
 [XI]  - L. BORGIANNI ET AL, "Mutational Analysis of VIM-2 Reveals an Essential Determinant for Metallo- -Lactamase Stability and Folding", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, US, (20100524), vol. 54, no. 8, doi:10.1128/AAC.01336-09, ISSN 0066-4804, pages 3197 - 3204, XP055269017 [X] 1,11,12,19,21,23,25,27,28 * the whole document, in particular page 3198, column 1, lines 29-32; page 3203, column 1, lines 13-20 * [I] 2-10,13-18,20,22,24,26

DOI:   http://dx.doi.org/10.1128/AAC.01336-09
 [A]  - L. POIREL ET AL, "OXA-48-like carbapenemases: the phantom menace", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (20120411), vol. 67, no. 7, doi:10.1093/jac/dks121, ISSN 0305-7453, pages 1597 - 1606, XP055059209 [A] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1093/jac/dks121
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.